Streetbeat News

MAX

MediaAlpha, Inc.

https://www.mediaalpha.com

Industry

Internet Content & Information

MediaAlpha, Inc., through its subsidiaries, operates an insurance customer acquisition platform in the United States. It optimizes customer acquisition in various verticals of property and casualty insurance, health insurance, and life insurance. The company was founded in 2014 and is headquartered in Los Angeles, California. MediaAlpha, Inc. is a subsidiary of White Mountains Insurance Group, Ltd.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Goldman Sachs initiated coverage on MediaAlpha, Inc. (NYSE:MAX) with a Buy rating and a $20 price target, citing growth in the insurance digital advertising market. Analyst Eric Sheridan highlights the company's potential in the P&C market recovery and digital channel expansion. MediaAlpha's recent financial performance exceeded expectations.

Portfolio Pulse from Lekha Gupta

August 20, 2024 | 5:43 pm

Goldman Sachs has initiated coverage on MediaAlpha (NYSE:MAX) with a Buy rating and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:23 am

Wolfpack Research has criticized MAX's CEO Steven Yi for his comments during the earnings call, accusing the company of using fraudulent ads and deceptive websites. They highlighted an ongoing FTC investigation and questioned the company's internal investigation. Wolfpack also noted potential negative impacts from upcoming FCC regulations.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 3:15 pm

Keefe, Bruyette & Woods analyst Tommy McJoynt has reiterated an Outperform rating on MediaAlpha (NYSE:MAX) and raised the price target from $25 to $26.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 2:11 pm

Carvana Co. (NYSE:CVNA) shares surged 13.4% in pre-market trading after reporting better-than-expected Q2 financial results. Other notable pre-market movers include FSD Pharma Inc. (NASDAQ:HUGE), Immuneering Corporation (NASDAQ:IMRX), and CareDx, Inc (NASDAQ:CDNA) among gainers, while ALX Oncology Holdings Inc. (NASDAQ:ALXO) and Teladoc Health, Inc. (NYSE:TDOC) were among the losers.

Portfolio Pulse from Avi Kapoor

August 01, 2024 | 12:32 pm

MediaAlpha shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:15 am

MediaAlpha has projected its Q3 revenue to be between $240 million and $255 million.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:28 pm

MediaAlpha shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:00 pm

MediaAlpha (NYSE:MAX) reported Q2 2024 earnings per share of $0.07, significantly beating the analyst estimate of $(0.03). The company also reported sales of $178.274 million, surpassing the $151.419 million estimate and marking a 110.42% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:37 pm

The article highlights three oversold stocks in the communication services sector that may present buying opportunities: Orange SA (ORAN), MediaAlpha Inc (MAX), and Baidu Inc (BIDU). These stocks have RSI values below 30, indicating they are oversold. Analysts have recently provided ratings and price target updates for these companies.

Portfolio Pulse from Avi Kapoor

June 28, 2024 | 11:12 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.